1,3-diphenylpropan-1-ones as allosteric modulators of α7 nACh receptors with analgesic and antioxidant properties

被引:14
作者
Criado, Manuel [1 ]
Balsera, Beatriz [2 ]
Mulet, Jose [1 ]
Sala, Salvador [1 ]
Sala, Francisco [1 ]
de la Torre-Martinez, Roberto [3 ]
Fernandez-Carvajal, Asia [3 ]
Ferrer-Montiel, Antonio [3 ]
Moreno-Fernandez, Silvia [4 ]
Miguel, Marta [4 ]
Perez de Vega, Maria Jesus [2 ]
Gonzalez-Muniz, Rosario [2 ]
机构
[1] Univ Miguel Hernandez CSIC, Inst Neurociencias, Sant Joan dAlacant 03050, Spain
[2] IQM CSIC, Inst Quim Med, Juan Cierva 3, Madrid 28006, Spain
[3] Univ Miguel Hernandez, Inst Biol Mol & Celular, Ave Univ S-N, Elche 03202, Alicante, Spain
[4] CEI UAM, CSIC UAM, Inst Invest Ciencias Alimentac, C Nicolas Cabrera 9, Madrid 28049, Spain
关键词
alpha; 7; nAChR; antioxidant; inflammation; pain; positive allosteric modulator; NICOTINIC ACETYLCHOLINE-RECEPTOR; VITRO PHARMACOLOGICAL CHARACTERIZATION; IN-VIVO; NEUROPATHIC PAIN; VAGUS NERVE; 4-(5-(4-CHLOROPHENYL)-2-METHYL-3-PROPIONYL-1H-PYRROL-1-YL)BENZENESULFONAMIDE A-867744; ANTIINFLAMMATORY PATHWAY; COGNITIVE DEFICITS; FLAVONOIDS; DISCOVERY;
D O I
10.4155/fmc-2015-0001
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Nicotine acethylcholine receptors (nAChRs) play critical roles in cognitive processes, neuroprotection and inflammation. Results: According to their substituents, 1,3-diphenylpropan-1-one derivatives act as alpha 7 nAChRs negative allosteric modulators (NAM, OMe) or Type I positive allosteric modulators (PAMs, OH). Compounds 7 and 31 were the most effective (989 and 666% enhancement of ACh-induced currents) and potent (EC50 : 12.9 and 6.85 mu M) PAMs. They exhibited strong radical scavenging values. Compound 31, selective over other neuronal nAChR subtypes and with acceptable pharmacokinetic profile, showed antinociceptive effects in a model of inflammatory pain. Conclusion: Compound 31 is a novel, potent and selective alpha 7 nAChR PAM, displaying antioxidant and analgesic activities. The 1,3-diphenylpropan-1-one scaffold could be the base toward more advanced type I PAMs for the treatment of n-AChR-mediated diseases.
引用
收藏
页码:731 / 749
页数:19
相关论文
共 55 条
[21]   Distinct profiles of α7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes [J].
Gronlien, Jens Halvard ;
Hakerud, Monika ;
Ween, Hilde ;
Thorin-Hagene, Kirsten ;
Briggs, Clark A. ;
Gopalakrishnan, Murali ;
Malysz, John .
MOLECULAR PHARMACOLOGY, 2007, 72 (03) :715-724
[22]   Chlorogenic acid administered intrathecally alleviates mechanical and cold hyperalgesia in a rat neuropathic pain model [J].
Hara, Koji ;
Haranishi, Yasunori ;
Kataoka, Kazunori ;
Takahashi, Yoshihiro ;
Terada, Tadanori ;
Nakamura, Motohiro ;
Sata, Takeyoshi .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 723 :459-464
[23]   Design, Synthesis, and Activity of a Series of Arylpyrid-3-ylmethanones as Type I Positive Allosteric Modulators of α7 Nicotinic Acetylcholine Receptors [J].
Hogenkamp, Derk J. ;
Ford-Hutchinson, Thomas A. ;
Li, Wen-Yen ;
Whittemore, Edward R. ;
Yoshimura, Ryan F. ;
Tran, Minhtam B. ;
Johnstone, Timothy B. C. ;
Bascom, Gavin D. ;
Rollins, Hannah ;
Lu, Lena ;
Gee, Kelvin W. .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (21) :8352-8365
[24]  
Hormaza Angelina, 2009, Rev. Soc. Quím. Perú, V75, P12
[25]   A novel positive allosteric modulator of the α7 neuronal nicotinic acetylcholine receptor:: In vitro and in vivo characterization [J].
Hurst, RS ;
Hajós, M ;
Raggenbass, M ;
Wall, TM ;
Higdon, NR ;
Lawson, JA ;
Rutherford-Root, KL ;
Berkenpas, MB ;
Hoffmann, WE ;
Piotrowski, DW ;
Groppi, VE ;
Allaman, G ;
Ogier, R ;
Bertrand, S ;
Bertrand, D ;
Arneric, SP .
JOURNAL OF NEUROSCIENCE, 2005, 25 (17) :4396-4405
[26]   Cocoa and Chocolate in Human Health and Disease [J].
Katz, David L. ;
Doughty, Kim ;
Ali, Ather .
ANTIOXIDANTS & REDOX SIGNALING, 2011, 15 (10) :2779-2811
[27]   In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties [J].
Kennett, GA ;
Wood, MD ;
Bright, F ;
Cilia, J ;
Piper, DC ;
Gager, T ;
Thomas, D ;
Baxter, GS ;
Forbes, IT ;
Ham, P ;
Blackburn, TP .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (03) :427-434
[29]   In Vitro Pharmacological Characterization of a Novel Selective α7 Neuronal Nicotinic Acetylcholine Receptor Agonist ABT-107 [J].
Malysz, John ;
Anderson, David J. ;
Gronlien, Jens H. ;
Ji, Jianguo ;
Bunnelle, William H. ;
Hakerud, Monika ;
Thorin-Hagene, Kirten ;
Ween, Hilde ;
Helfrich, Rosalind ;
Hu, Min ;
Gubbins, Earl ;
Gopalakrishnan, Sujatha ;
Puttfarcken, Pamela S. ;
Briggs, Clark A. ;
Li, Jinhe ;
Meyer, Michael D. ;
Dyhring, Tino ;
Ahring, Philip K. ;
Nielsen, Elsebet O. ;
Peters, Dan ;
Timmermann, Daniel B. ;
Gopalakrishnan, Murali .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (03) :863-874
[30]   In Vitro Pharmacological Characterization of a Novel Allosteric Modulator of α7 Neuronal Acetylcholine Receptor, 4-(5-(4-Chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), Exhibiting Unique Pharmacological Profile [J].
Malysz, John ;
Gronlien, Jens Halvard ;
Anderson, David J. ;
Hakerud, Monika ;
Thorin-Hagene, Kirsten ;
Ween, Hilde ;
Wetterstrand, Caroline ;
Briggs, Clark A. ;
Faghih, Ramin ;
Bunnelle, William H. ;
Gopalakrishnan, Murali .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (01) :257-267